Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer

Clinical trial NCT00153881 · COMPLETED

Trial details

NCT number: NCT00153881
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Neoplasms

Start date: 2000-02-01
Primary completion: 2013-09-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.